🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust market exists on messaging services, where groups with numerous of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and customer laws, potentially leading to penalties, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the service has removed violative material and banned associated keywords and query recommendations. The organization said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also found communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of slimming results, positive testimonials and detailed guides for preparing or administering at home.

Within minutes of joining one community, a seller shared contact information, where most purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Product Information and Pricing

Inside these groups, posts show black plastic packages with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it actively monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Although the research behind retatrutide is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to possibly significant health risks”.